Skip to main content
SpringerLink
Log in

Mogamulizumab-induced toxicoderma-like eruptions and autoimmune hepatitis successfully treated with azathioprine in adult T-cell leukaemia/lymphoma

  • Correspondence
  • Published:
European Journal of Dermatology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Takahashi H, Zeniya M. Acute presentation of autoimmune hepatitis: does it exist? A published work review. Hepatol Res 2011; 41: 498–504.

    Article  Google Scholar 

  2. Ishii T, Ishida T, Utsunomiya A, et al. Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma. Clin Cancer Res 2010; 16: 1520–31.

    Article  CAS  Google Scholar 

  3. Ni X, Jorgensen JL, Goswami M, et al. Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sezary syndrome. Clin Cancer Res 2015; 21: 274–85.

    Article  CAS  Google Scholar 

  4. Ishida T, Ito A, Sato F, et al. Stevens-Johnson syndrome associated with mogamulizumab treatment of adult T-cell leukemia/lymphoma. Cancer Sci 2013; 104: 647–50.

    Article  CAS  Google Scholar 

  5. Ishitsuka K, Murahashi M, Katsuya H, et al. Colitis mimicking graftversus-host disease during treatment with the anti-CCR4 monoclonal antibody, mogamulizumab. Int J Hematol 2015; 102: 493–7.

    Article  Google Scholar 

  6. Nakano N, Kusumoto S, Tanaka Y, et al. Reactivation of hepatitis B virus in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab. Hepatol Res 2014; 44: 354–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, National Defense Medical College, Tokorozawa, Japan

    Aya Nishizawa, Takahiro Ishikawa, Miki Hirose, Hitomi Satoh & Takahiro Satoh

  2. Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan

    Shin Nishii, Kengo Tomita & Ryota Hokari

Authors
  1. Aya Nishizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takahiro Ishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miki Hirose
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hitomi Satoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shin Nishii
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kengo Tomita
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ryota Hokari
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takahiro Satoh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aya Nishizawa.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nishizawa, A., Ishikawa, T., Hirose, M. et al. Mogamulizumab-induced toxicoderma-like eruptions and autoimmune hepatitis successfully treated with azathioprine in adult T-cell leukaemia/lymphoma. Eur J Dermatol 27, 651–652 (2017). https://doi.org/10.1684/ejd.2017.3103

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2017.3103

Search

Navigation